Medline Inc（MDLN）财务数据MDLNMedline Inc

Medline Inc. (MDLN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Supply Chain Solutions, accounting for 53.9% of total sales, equivalent to $4.14B. Other significant revenue streams include Medline Brand - Front Line Care and Medline Brand - Surgical Solutions. Understanding this composition is critical for investors evaluating how MDLN navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Medline Inc. maintains a gross margin of 26.52%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 9.89%, while the net margin is 1.81%. These profitability ratios, combined with a Return on Equity (ROE) of 4.92%, provide a clear picture of how effectively MDLN converts its operational activities into shareholder value.

In the context of the broader market, MDLN competes directly with industry leaders such as A and EW. With a market capitalization of $45.94B, it holds a significant position in the sector. When comparing efficiency, MDLN's gross margin of 26.52% stands against A's 55.54% and EW's 77.46%. Such benchmarking helps identify whether Medline Inc. is trading at a premium or discount relative to its financial performance.

Medline reported a strong Q2 with revenues of $7.7 billion, an 11.6% year-over-year increase, and a non-GAAP EPS of $0.50, beating expectations by $0.18. However, net income has shown volatility, with a significant drop in Q2 2026 net income to $59 million from $132 million in Q1 2026.